"Increase in various antimicrobial resistance bacteria threatens the conventional antimicrobial therapy, the development of new antimicrobial drug and therapy has been required all over the world.
Our major projects are focused as followings: (i) development of a new adjuvant from the bacterial components; (ii) study of a new treatment of sepsis using liposomes; (iii) analysis of infection mechanisms of bacterial pathogens using molecular-biological techniques."